Revolution Medicines, Inc. Warrant (RVMDW) stock analysis
In our weekly check, Revolution Medicines, Inc. Warrant is graded F (A to F). Of 22 checks on debt, profit, cash flow and trend: 6 pass, warnings: 3, red flags: 13.
About Revolution Medicines, Inc. Warrant
Revolution Medicines, Inc. Warrant is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as RVMDW.
What our checks show for RVMDW
Red flags
- The company has net debt but no positive operating earnings (EBITDA) to service it from (debt/equity 0.27).
- The company has an operating loss, so it does not cover the interest bill: interest is paid from cash or new debt.
- The net margin fell by 310 points over 5 years, to -947%: the company keeps less of each sale as profit.
- The gross margin fell by 4.8 points, to 95.2%: costs are rising faster than prices.
- Weak EPS growth
- The company is losing money: the net margin is -947%.
- Free cash flow is negative (-729% of revenue): the business spends more cash than it brings in.
- The price swings a lot: 157% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 97% from a peak. Would you have held through that?
- The share count grew by 68% in 2 years: each shareholder owns a smaller slice.
- Thinly traded (about 34 thousand shares a day): buying and selling can move the price.
- Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.
- Free cash flow is negative, so no cash is left over to cover pay in shares.
Warning signs
- Operating cash flow is negative while the company reports a profit: the profit does not arrive as cash.
- Analysts expect earnings per share to shrink about 68.8% a year.
- Beta 1.4: the stock usually moves more than the market, both up and down.
Strengths
- Analysts expect revenue to grow about 252% a year over the next years.
- Analysts expect the net margin to improve by 951 points from today's -947%.
- Revenue grew 77.4% a year over the last 3 years.
- A large company: market value $35.92 billion.
Similar companies
GMAB · ONC · ROIV · INSM · UTHR · INCY
Questions
What grade does Revolution Medicines, Inc. Warrant (RVMDW) have?
In our weekly check, Revolution Medicines, Inc. Warrant is graded F (A to F). Of 22 checks on debt, profit, cash flow and trend: 6 pass, warnings: 3, red flags: 13. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of RVMDW stock?
This week's biggest flags for Revolution Medicines, Inc. Warrant: High debt, Weak interest cover, Margins falling. In total 16 of 22 checks show a warning or a red flag.
What does Revolution Medicines, Inc. Warrant do?
Revolution Medicines, Inc. Warrant is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as RVMDW.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis